Dave Muoio

AT&T Business' Clint Cetti gives a rundown of new health technologies that could benefit from increased capacity and speed, as well as some key considerations for health systems planning to implement the next-generation network.

Also: Datos Health ties off $7 million in Series A funding; Wellthy Therapeutics collects $4 million in pre-Series A; Lifesprk fleshes out tech with $16.1 million.

Amid COVID-19, a new 1,000-person survey suggests high demand for remote health services.

The two tech giants' unprecedented partnership looks to engage as many users in disease-tracing and prevention efforts as possible while tearing down the data silos of their respective smartphone platforms.

The in-development system foregoes GPS tracking and other identifying data collection methods in its effort to automate labor-intensive COVID-19 contact tracing. 

Also: FDA COVID-19 policy allows for remote use, digital modifications to ophthalmic devices; 23andMe launches genetics study to understand varying COVID-19 responses.

Certain healthcare use cases are ripe for AI, but still must provide a human touch to truly benefit patient experience. 

The company is tripling its physician pool by the end of April, and has launched a new patient dashboard.

From 2000 to 2017, the number of registered clinical trials featuring CGMs, apps and other connected devices rose at a 34% CAGR, according to new data from Harvard researchers.

The new investment brings the medical cybersecurity startup's total raise to $30 million.